AINDEX
Markets

ResMed Inc. (RMD)

RMDNYSEMedical/Dental Instruments

$235.74

+0.2100 (+0.09%) today

At the close, Nov 9, 4:00 PM ET. Pre-market $240.56 +2.04%

+0.85% 1D
Market cap
$33.84bn
P/E
20.4
EPS, last 4 quarters
$11.53
Dividend yield
–
Day range
–
52-week range
$180.27 to $277.67
Average volume
637.3k
Previous close
$235.53

Analysts

12 covering

Hold5 buy, 7 hold, 0 sell

Targets a year out average $261.73, +11.0% from here

$230.00now $235.74$320.00

Earnings

next estimate $3.03

Next report

Dec 2025

+4.5%

Mar 2026

+2.5%

Jun 2026

+1.7%

Sep 2026

+9.0%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.42bn$1.43bn$1.46bn$1.41bn
Gross profit$881.88m$890.98m$861.22m$870.57m
Operating income$491.66m$499.81m$448.71m$452.98m
Net income$392.59m$398.73m$383.43m$418.41m

Last four quarters: revenue $5.73bn, margin 27.8%, free cash flow $1.61bn

News

8 latest

The company

Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We're relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we're redefining sleep health at Resmed.com and follow @Resmed.

Sector
Health Care
Industry
Medical/Dental Instruments
Exchange
NYSE
Region
North America
Website
resmed.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.